{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:08:35Z","timestamp":1747163315085,"version":"3.40.5"},"reference-count":9,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jaccas.2024.102454","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T10:56:08Z","timestamp":1724410568000},"page":"102454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mavacamten Safety and Efficacy in a Heart Transplant Patient Exhibiting Obstructive Hypertrophic Cardiomyopathy Phenotype"],"prefix":"10.1016","volume":"29","author":[{"given":"Zaid","family":"Abood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Ghafoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muddasir","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5952-7996","authenticated-orcid":false,"given":"Patrycja","family":"Galazka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Misicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5072-710X","authenticated-orcid":false,"given":"M. Fuad","family":"Jan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5582-3336","authenticated-orcid":false,"given":"Arshad","family":"Jahangir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-1275","authenticated-orcid":false,"given":"A. Jamil","family":"Tajik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccas.2024.102454_bib1","first-page":"S322","article-title":"Incidence and treatment of arterial hypertension after heart transplantation","volume":"41","author":"Lumish","year":"2022","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jaccas.2024.102454_bib2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.healun.2011.08.003","article-title":"The Registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report--2011","volume":"30","author":"Stehlik","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jaccas.2024.102454_bib3","first-page":"269","article-title":"Pathogenesis of calcineurin inhibitor-induced hypertension","volume":"25","author":"Hoorn","year":"2012","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.jaccas.2024.102454_bib4","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1093\/eurheartj\/ehn407","article-title":"Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients","volume":"29","author":"Kushwaha","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccas.2024.102454_bib5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/hc3101.093765","article-title":"Cardiac hypertrophy after transplantation is associated with persistent expression of tumor necrosis factor-alpha","volume":"104","author":"Stetson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jaccas.2024.102454_bib6","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.15829\/1560-4071-2021-4625","article-title":"Hypertrophic obstructive cardiomyopathy in a heart transplant recipient: a case report","volume":"26","author":"Golovina","year":"2021","journal-title":"Russ J Cardiol"},{"key":"10.1016\/j.jaccas.2024.102454_bib7","article-title":"Hypertrophic cardiomyopathy after heart transplantation: a single-center case series","volume":"14","author":"Gao","year":"2023","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.jaccas.2024.102454_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A\u00a0small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jaccas.2024.102454_bib9","doi-asserted-by":"crossref","first-page":"H881","DOI":"10.1152\/ajpheart.00345.2020","article-title":"Mavacamten decreases maximal force and Ca(2+) sensitivity in the N47K-myosin regulatory light chain mouse model of hypertrophic cardiomyopathy","volume":"320","author":"Awinda","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266608492400247X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266608492400247X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T10:56:15Z","timestamp":1724410575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266608492400247X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":9,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S266608492400247X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2024.102454","relation":{},"ISSN":["2666-0849"],"issn-type":[{"type":"print","value":"2666-0849"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mavacamten Safety and Efficacy in a Heart Transplant Patient Exhibiting Obstructive Hypertrophic Cardiomyopathy Phenotype","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2024.102454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102454"}}